Literature DB >> 10770552

The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy.

D C Melvin, J K Lee, E Belsey, J Arnold, R L Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10770552     DOI： 10.1097/00002030-200003100-00023

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Management of Hepatitis C in HIV-infected Patients.

Authors:  Benigno Rodriguez; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

2.  HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.

Authors:  Hannah Fraser; Christinah Mukandavire; Natasha K Martin; Matthew Hickman; Myron S Cohen; William C Miller; Peter Vickerman
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

3.  HIV-HCV Coinfection.

Authors:  Amrita Sethi; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

4.  Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients.

Authors:  Paula Braitstein; Benita Yip; Valentina Montessori; David Moore; Julio S G Montaner; Robert S Hogg
Journal:  CMAJ       Date:  2005-07-19       Impact factor: 8.262

5.  Issues in HIV/Hepatitis C Co-infection.

Authors:  Jonathan P. Moorman
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

6.  Characteristics of hepatitis C virus infection in HIV-infected people.

Authors:  C L Cooper; A D Badley; J B Angel
Journal:  Can J Infect Dis       Date:  2001-05

Review 7.  Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.

Authors:  Vincent Lo Re; Jay R Kostman; Valerianna K Amorosa
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

8.  Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial.

Authors:  Mandana Khalili; David Bernstein; Ellen Lentz; Christine Barylski; Margaret Hoffman-Terry
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.487

Review 9.  Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?

Authors:  Athanasios-Dimitrios Bakasis; Theodoros Androutsakos
Journal:  Cells       Date:  2021-05-15       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.